RE:Was in BNC Now IN SDI Spectral Diagnostics is the Real Deal
We had an intentional pumper installed here when we earned FDA approval for our West nile assay. Oddly, it wasn't a "pro pumper" like I've found on other sites, it was an "over the top pumper' designed to "turn people off". You suggesting this goes to $50 would turn SDI into an 8 BILLION DOLLAR firm......"that's NOT going to happen" Gecko. A suggestion of $3 - $5 pershare is VERY reasonable.
The opportunity for the EAA is massive. We have full global rights to this FDA approved ( Gold Standard ) It already has, and will continue to be packaged with Toraymyxin columns to form the "theranostic"
Rogo, I think you misread the potential for EAA usage in Nord America. Nearly 2M EAA tests are possible annually, as ALL 1M sepsis are potential candidates for the diagnostic to help stage their treatment plan ( welcome to "personalized medicine" ) The additional million would come via those being treated by Toraymyxin ( PMX ). Patients undergoing the hemoperfusion therapy would need to by screened and monitored with the EAA diagnostic.
Additionally, the EAA will be used in any organ related treatment, as "da proof is da proof", time and time again, it's been proven that HIGH ENDOTOXIN levels lead to worse outcomes for critically ill patients. Dr. Paul Walker and his friend Alex Romaschin ( spell ) could very well find the themselves as legends in the field of critical care, thanks to an invention from 1994...The EAA ( Endotoxin Activity Assay )
Sqr